期刊文献+

TNF-α、IL-6及HE4和CA125在EAOC患者中的诊断价值 被引量:17

Application of TNF-α,IL-6,HE4 and CA125 in diagnosis of EAOC
下载PDF
导出
摘要 目的:探讨肿瘤坏死因子(TNF-α)、白细胞介素6(IL-6)、肿瘤标志物人附睾蛋白4(HE4)及糖类抗原125(CA125)在子宫内膜异位症相关性卵巢癌患者中水平变化,并分析其在癌症早期诊断中的应用价值。方法:回顾性分析2014年7月~2018年9月在唐山市妇幼保健院收治的84例卵巢癌患者,其中子宫内膜异位症相关性卵巢癌(EAOC)患者52例,卵巢浆液性腺癌32例;卵巢良性肿瘤患者30例,子宫内膜异位症(EM)患者35例,另外选取同期健康体检妇女50例为对照组。采用微粒子化学发光法检测受检者HE4和CA125含量;酶联吸附实验(ELISA)测定TNF和IL-6含量。结果:HE4、CA125及IL-6和TNF-α在EAOC组的水平低于浆液性卵巢癌组,而高于卵巢良性肿瘤组和对照组(P<0.05);HE4、CA125及IL-6和TNF-α在EAOC组Ⅲ、Ⅳ期的水平明显高于Ⅰ期和Ⅱ期(P<0.05);各指标在低分化组高于高分化组(P<0.05);HE4与CA125和IL-6均呈正相关,相关系数分别为(r=0.415,P<0.05;r=0.362,P<0.05);HE4及IL-6联合诊断EAOC价值最高。结论:炎症因子IL-6和TNF-α和肿瘤标志物HE4及CA125在辅助诊断EAOC方面具有较高价值。 Objective:To investigate the changes of inflammatory factors-tumor necrosis factor-alpha(TNF-α),interleukin-6(IL-6),human epididymal protein 4(HE4)and carbohydrateantigen 125(CA125)in patients with endometriosis-related ovarian cancer,and to analyze their value in early diagnosis of cancer.Methods:84 cases of ovarian tumor patients were retrospectively analyzed which admitted to Tangshan Women and Children′s Health Hospital from July 2014 to December 2017.Among of them,52 patients were endometriosis-related ovarian cancer(EAOC),32 patients were ovarian adenocarcinoma;30 patients were benign ovarian tumors and 35 patients were endometriosis(EM)and 50 healthy controls were selected.Levels of HE4 and CA125 were detected by chemiluminescence method,and levels of TNF-αand IL-6 were determined by enzyme-linked sorption assay(ELISA).Results:Levels of HE4,CA125,IL-6 and TNF-αin EAOC group were lower than those in serous ovarian cancer group,but higher than those in benign ovarian tumors group and control group(P<0.05);levels of HE4,CA125,IL-6 and TNF-αin stageⅢandⅣof EAOC group were significantly higher than those in stageⅠandⅡof EAOC group(P<0.05);levels in low differentiation group were higher than those in high differentiation group(P<0.05);HE4 was positively correlated with CA125 and IL-6,respectively,which of the correlation coefficients were(r=0.415,P<0.05;r=0.362,P<0.05),ROC curve analysis showed that HE4 and IL-6 combined diagnostic efficiency was higher than that two used alone in the diagnosis of EAOC Conclusion:Detection of IL-6,TNF-α,HE4 and CA125 have high diagnostic value in assistant diagnosis of EAOC.
作者 高翠红 孙文杰 于艳丽 崔娇姣 周鹏翔 杜潘艳 蒙长虹 GAO Cui-Hong;SUN Wen-Jie;YU Yan-Li;CUI Jiao-Jiao;ZHOU Peng-Xiang;DU Pan-Yan;MENG Chang-Hong(Department of Clinical Laboratory of Tangshan Women and Children′s Health Hospital,Tangshan 063000,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2020年第12期1485-1488,1493,共5页 Chinese Journal of Immunology
基金 河北省2019年医学科学研究计划(20191531)资助。
关键词 子宫内膜异位症相关性卵巢癌 TNF-Α IL-6 HE4 CA125 子宫内膜异位症 Endometriosis-associated ovarian cancer Tumor necrosis factor Interleukin-6 Human epididymis protein 4 Carbohydrateantigen 125 Endometriosis
  • 相关文献

参考文献5

二级参考文献40

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 2秦海明,万楠,王璐,王晓辰.VEGF、CA15-3、CA125和CEA在乳腺癌诊断及预后判断中的应用[J].中国肿瘤临床与康复,2006,13(6):497-498. 被引量:4
  • 3Coughlin S S,Ekwueme D U.Breast cancer as a global health concern[J].Cancer Epidemiology,2009,33:315.
  • 4Héry C,Ferlay J,Boniol M,et al.Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations[J].Annals of Oncology,2008,19:1009.
  • 5Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer[J].Journal of Clinical Oncology,2007,25:5287.
  • 6Abd Hamid U M,Royle L,Saldova R,et al.A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression[J].Glycobiology,2008,18:1105.
  • 7Skates S J,Horick N K,Moy J M,et al.Pooling of case specimens to create standard serum sets for screening cancer biomarkers[J].Cancer Epidemiology,Biomarkers & Prevention,2007,16(2):334.
  • 8Hellstrom I,Raycraft J,Hayden-Ledbetter M,et al.The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Research . 2003
  • 9Fioretti P,Gadducci A,Ferdeghini M,Prontera C,Malagnino G,Facchini V,Mariani G,Bianchi R.The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients. Gynecologic Oncology . 1992
  • 10赵阳.血清HE4、CA125和YKL-40联合检测在上皮性卵巢癌诊断中的临床价值[D].山西医科大学2014

共引文献114

同被引文献178

引证文献17

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部